CVE-2025-24807

CVE-2025-24807 is a high-severity vulnerability in Eprosima Fast Dds with a CVSS 3.x base score of 7.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-345.

Key facts

Description

eprosima Fast DDS is a C++ implementation of the DDS (Data Distribution Service) standard of the OMG (Object Management Group). Prior to versions 2.6.10, 2.10.7, 2.14.5, 3.0.2, 3.1.2, and 3.2.0, per design, PermissionsCA is not full chain validated, nor is the expiration date validated. Access control plugin validates only the S/MIME signature which causes an expired PermissionsCA to be taken as valid. Even though this issue is responsible for allowing `governance/permissions` from an expired PermissionsCA and having the system crash when PermissionsCA is not self-signed and contains the full-chain, the impact is low. Versions 2.6.10, 2.10.7, 2.14.5, 3.0.2, 3.1.2, and 3.2.0 contain a fix for the issue.

Frequently asked questions

What is CVE-2025-24807?
eprosima Fast DDS is a C++ implementation of the DDS (Data Distribution Service) standard of the OMG (Object Management Group). Prior to versions 2.6.10, 2.10.7, 2.14.5, 3.0.2, 3.1.2, and 3.2.0, per design, PermissionsCA is not full chain validated, nor is the expiration date validated. Access control plugin validates only the S/MIME signature which causes an expired PermissionsCA to be taken as valid. Even though this issue is responsible for allowing `governance/permissions` from an expired PermissionsCA and having the system crash when PermissionsCA is not self-signed and contains the full-chain, the impact is low. Versions 2.6.10, 2.10.7, 2.14.5, 3.0.2, 3.1.2, and 3.2.0 contain a fix for the issue.
How severe is CVE-2025-24807?
CVE-2025-24807 has a CVSS 3.x base score of 7.1, rated high severity. It is exploitable over local access with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability high.
Is CVE-2025-24807 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (9th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2025-24807?
CVE-2025-24807 affects Eprosima Fast Dds. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2025-24807?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
Does CVE-2025-24807 have an EU (EUVD) identifier?
Yes. CVE-2025-24807 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-3949.
When was CVE-2025-24807 published?
CVE-2025-24807 was published on 2025-02-11 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Eprosima Fast Dds

All CVEs affecting Eprosima Fast Dds →

Other CWE-345 (Insufficient Verification of Data Authenticity) vulnerabilities

Browse all CWE-345 (Insufficient Verification of Data Authenticity) vulnerabilities →